(Alliance News) - The FTSE 100 fell heavily on Friday as bond yields pushed higher amid fears that higher inflation will keep interest rates elevated. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that Klygefa has been recommended for approval in the EU, as a treatment for generalised myasthenia gravis. Read More
(Alliance News) - AstraZeneca PLC and its partner Daiichi Sankyo Co Ltd on Friday announced that their cancer drug Enhertu has been recommended to be approved in the EU for a form of breast cancer. Read More
(Alliance News) - Stock prices in London opened lower on Friday, despite stronger-than-expected UK retail sales, as weakness in Airtel Africa weighed on the FTSE 100. Read More
(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration granted a 'priority review' designation for efzimfotase alfa, an investigational enzyme replacement therapy. Read More
(Alliance News) - UK retail sales rebound in August and beat market expectations. AstraZeneca's efzimfotase alfa receives 'Priority Review' in the US for the treatment of hypophosphatasia, while Softcat raises GBP354 million to help fund its USD1.05 billion acquisition of GDT. Read More
(Alliance News) - Daiichi Sankyo Co Ltd on Wednesday said that its breast cancer drugs, Enhertu and Datroway, which are being developed in partnership with AstraZeneca PLC, have been approved for new indications in Japan. Read More
(Alliance News) - UK inflation accelerates to 3.1% in August as higher fuel costs drive prices higher. Barratt Redrow reports a rise in annual pretax profit but lowers its home completions guidance, while Babcock says trading is in line with expectations and leaves its outlook unchanged. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceutical firm - Non-Executive Chair Michel Demare buys 2,500 shares at 12,121.33 pence each, for GBP303,033 in total, on Monday in London. Read More
(Alliance News) - Stock prices in London closed mixed on Monday, with Middle East tensions, AI slowdown fears and caution ahead of a flurry of central bank meetings keeping investors on their toes. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday reported their medicine Enhertu kept the disease from worsening for longer in patients with advanced lung cancer driven by a mutation in the gene that produces the human epidermal growth factor receptor 2. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its biologics licence application for tozorakimab in the US was accepted under priority review. Read More